Vimarsana
Biggest News Aggregation in the World

Page 2 - Induced Constipation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Induced Constipation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Induced Constipation Today - Breaking & Trending Today

Opioid Induced Constipation (OIC) Drugs Market to Reach USD 1.79 billion, Globally, by 2031 at 4.9% CAGR: Allied Market Research - Vimarsana News

Opioid Induced Constipation (OIC) Drugs Market to Reach USD 1.79 billion, Globally, by 2031 at 4.9% CAGR: Allied Market Research

/PRNewswire/ -- Allied Market Research published a report, titled, "Opioid Induced Constipation (OIC) Drugs Market by Drug Type (Mu-opioid Receptor...

Analgesics Market to register 5.6% CAGR between 2021 and 2031 - Vimarsana News

Analgesics Market to register 5.6% CAGR between 2021 and 2031

The latest study by Future Market Insight (FMI) provides insights into the governing factors facilitating the growth in the analgesics market. It also examines scope of expansion across various segments in terms of drug class, indication, route of administration, and distribution channel. The study also uncovers cha...

Opioid-Induced Constipation (OIC) Treatment Market Insights, New Innovations, Research and Growth Fa - Vimarsana News

Opioid-Induced Constipation (OIC) Treatment Market Insights, New Innovations, Research and Growth Fa

Opioids are a class of medications that are regularly endorsed for their pain relieving, or pain-killing, properties it is chronic and non-cancer pain. A typical symptom connected with the utilization of these medications are that they decrease the gastrointestinal tract’s motility, making solid discharges and makin...

New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix's RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy - Vimarsana News

New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix's RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy

Research Reveals Reduction in Hospitalization Rates, Length of Stay and Health Care Costs When Treating OIC with FDA-Approved Prescription Medications LAVAL, QC, March 24, 2022 /PRNewswire/ --... | March 24, 2022

Analgesics Market Value Surpasses US$ 77.3 Bn as Demand for - Vimarsana News

Analgesics Market Value Surpasses US$ 77.3 Bn as Demand for

DUBAI, United Arab Emirates, Jan. 13, 2022 (GLOBE NEWSWIRE) -- The latest study by Future Market Insight (FMI) provides insights into the governing...